A Novel Model of SCID-X1 Reconstitution Reveals Predisposition to Retrovirus-induced Lymphoma but No Evidence of γC Gene Oncogenicity
Open Access
- 1 June 2009
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (6), 1031-1038
- https://doi.org/10.1038/mt.2009.59
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsJournal of Clinical Investigation, 2008
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Journal of Clinical Investigation, 2008
- Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytesMolecular Immunology, 2008
- Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cellsBlood, 2007
- Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivoJournal of Clinical Investigation, 2007
- Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapyJournal of Clinical Investigation, 2007
- Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapyProceedings of the National Academy of Sciences, 2006
- Transgenic mice with hematopoietic and lymphoid specific expression of CreEuropean Journal of Immunology, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Leukemogenesis by Moloney murine leukemia virus: A multistep processTrends in Microbiology, 1997